AbbVie reported its third quarter 2015 financial results. The company reported $5.944 billion in worldwide sales for the third quarter, an 18.4 percent year-over-year increase.
Timothy Pratt, an executive vice president at Boston Scientific, sold 3,500 shares of company stock for a total transaction value of $63,000, according to a Financial Wisdom report.
Exact Sciences, the company behind Cologuard, hopes to establish a headquarters in Madison, Wis., and is collaborating with the University of Wisconsin in Madison to develop a biotech campus.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
TIF procedure receives RVUs for new CPT code
Exact Sciences to help develop biotech campus in Madison
AGA pledges support for public-private microbiome initiative
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.